Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001104659-25-066702·Ovid Therapeutics Inc.
Schedule 13G ownership disclosure
Ovid therapeutics, Inc.
Common Stock, par value $0.001 per share · CUSIP: 690469101
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Rubric Capital Management LP
Shares: 478,533.00 · Class: 0.67%
- David Rosen
Shares: 478,533.00 · Class: 0.67%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-066702
- Form type
- SCHEDULE 13G/A
- Filer
- Ovid Therapeutics Inc.
- CIK
- CIK 1636651
- Filed
- Jul 09, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership